WHO ICTRP trial
Bacille-Calmette-Guerin (BCG) vaccine for multifocal motor neuropathy (MMN) and…
ACTRN12618001936213 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12618001936213 |
|---|---|
| Public title | Bacille-Calmette-Guerin (BCG) vaccine for multifocal motor neuropathy (MMN) and multifocal acquired demyelinating sensory and motor neuropathy (MADSAM). |
| Scientific title | Safety study of Bacille-Calmette-Guerin (BCG) for multifocal motor neuropathy (MMN) and multifocal acquired demyelinating sensory and motor neuropathy (MADSAM). |
| Primary sponsor | Sydney Local Health District |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Australia |
| Conditions | Multifocal motor neuropathy;Multifocal acquired demyelinating sensory and motor neuropathy (sometimes called asymmetric chronic inflammatory demyelinating polyradiculoneuropathy or Lewis Sumner syndrome); Multifocal motor neuropathy… |
| Interventions | Bacille Calmette Guerin (serum of institute of India) vaccine: single dose, intradermal injection into the upper arm, 0.1ml of reconstituted vaccine. This is given in addition to existing treatment such as intravenous immunoglobulin. |
| Registration date | Nov 28, 2018 |
| Target size | 20 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: